Total Funding
6
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 6 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2776803
PolyTherics provides a range of technologies and services to develop biomedical polymers for therapeutic applications.
- Ken Cunningham: Executive ChairmanPast Role: SkyePharma, CEO
- Sunil Shaunak: Co-Founder
About the Company
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised
clinical candidates.

